正在试验的新型冠状病毒（SARS-CoV-2）疫苗面临的潜在挑战。 - Suppr

Suppr

超能文献

Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial.

作者信息

Usmani Salman Sadullah, Raghava Gajendra P S

机构信息

Department of Computational Biology, Indraprastha Institute of Information Technology, New Delhi, India.

出版信息

Front Immunol. 2020 Sep 29;11:561851. doi: 10.3389/fimmu.2020.561851. eCollection 2020.

DOI:10.3389/fimmu.2020.561851

PMID:33133071

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7550622/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d51/7550622/bf19ec297f5c/fimmu-11-561851-g001.jpg

相似文献

Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial.

Front Immunol. 2020 Sep 29;11:561851. doi: 10.3389/fimmu.2020.561851. eCollection 2020.

A vaccine is not too far for COVID-19.

J Infect Dev Ctries. 2020 May 31;14(5):450-453. doi: 10.3855/jidc.12744.

SARS-CoV-2: A New Song Recalls an Old Melody.

Cell Host Microbe. 2020 May 13;27(5):692-694. doi: 10.1016/j.chom.2020.04.019.

COVID-19 shot protects monkeys.

Science. 2020 May 1;368(6490):456-457. doi: 10.1126/science.368.6490.456.

Is Herd Immunity Against SARS-CoV-2 a Silver Lining?

Front Immunol. 2020 Sep 30;11:586781. doi: 10.3389/fimmu.2020.586781. eCollection 2020.

Balancing Expediency and Scientific Rigor in Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development.

J Infect Dis. 2020 Jun 29;222(2):180-182. doi: 10.1093/infdis/jiaa234.

News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine.

Proc Natl Acad Sci U S A. 2020 Apr 14;117(15):8218-8221. doi: 10.1073/pnas.2005456117. Epub 2020 Mar 30.

COVID-19 vaccine design: the Janus face of immune enhancement.

Nat Rev Immunol. 2020 Jun;20(6):347-348. doi: 10.1038/s41577-020-0323-4. Epub 2020 Apr 28.

Developing Covid-19 Vaccines at Pandemic Speed.

N Engl J Med. 2020 May 21;382(21):1969-1973. doi: 10.1056/NEJMp2005630. Epub 2020 Mar 30.

Progress and Concept for COVID-19 Vaccine Development.

Biotechnol J. 2020 Jun;15(6):e2000147. doi: 10.1002/biot.202000147. Epub 2020 May 7.

引用本文的文献

A Web-Based Method for the Identification of IL6-Based Immunotoxicity in Vaccine Candidates.

Methods Mol Biol. 2023;2673:317-327. doi: 10.1007/978-1-0716-3239-0_22.

Changes of Host Immunity Mediated by IFN-γ CD8 T Cells in Children with Adenovirus Pneumonia in Different Severity of Illness.

Viruses. 2021 Nov 28;13(12):2384. doi: 10.3390/v13122384.

COVID-19 vaccines and nanomedicine.

Int J Dermatol. 2021 Sep;60(9):1047-1052. doi: 10.1111/ijd.15673. Epub 2021 Jun 5.

本文引用的文献

A Web-Based Platform on Coronavirus Disease-19 to Maintain Predicted Diagnostic, Drug, and Vaccine Candidates.

Monoclon Antib Immunodiagn Immunother. 2020 Dec;39(6):204-216. doi: 10.1089/mab.2020.0035. Epub 2020 Oct 30.

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.

Lancet. 2020 Aug 15;396(10249):467-478. doi: 10.1016/S0140-6736(20)31604-4. Epub 2020 Jul 20.

A perspective on potential antibody-dependent enhancement of SARS-CoV-2.

Nature. 2020 Aug;584(7821):353-363. doi: 10.1038/s41586-020-2538-8. Epub 2020 Jul 13.

Antibody Dependent Enhancement Due to Original Antigenic Sin and the Development of SARS.

Front Immunol. 2020 Jun 5;11:1120. doi: 10.3389/fimmu.2020.01120. eCollection 2020.

Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing.

Cell Discov. 2020 May 4;6:31. doi: 10.1038/s41421-020-0168-9. eCollection 2020.

Development of an inactivated vaccine candidate for SARS-CoV-2.

Science. 2020 Jul 3;369(6499):77-81. doi: 10.1126/science.abc1932. Epub 2020 May 6.

COVID-19: Therapeutics and Their Toxicities.

J Med Toxicol. 2020 Jul;16(3):284-294. doi: 10.1007/s13181-020-00777-5. Epub 2020 Apr 30.

Scores of coronavirus vaccines are in competition - how will scientists choose the best?

Nature. 2020 Apr 30. doi: 10.1038/d41586-020-01247-2.

The many faces of the anti-COVID immune response.

J Exp Med. 2020 Jun 1;217(6). doi: 10.1084/jem.20200678.

[Strategies for vaccine development of COVID-19].

Sheng Wu Gong Cheng Xue Bao. 2020 Apr 25;36(4):593-604. doi: 10.13345/j.cjb.200094.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial.

Front Immunol. 2020 Sep 29;11:561851. doi: 10.3389/fimmu.2020.561851. eCollection 2020.

A vaccine is not too far for COVID-19.

J Infect Dev Ctries. 2020 May 31;14(5):450-453. doi: 10.3855/jidc.12744.

SARS-CoV-2: A New Song Recalls an Old Melody.

Cell Host Microbe. 2020 May 13;27(5):692-694. doi: 10.1016/j.chom.2020.04.019.

COVID-19 shot protects monkeys.

Science. 2020 May 1;368(6490):456-457. doi: 10.1126/science.368.6490.456.

Is Herd Immunity Against SARS-CoV-2 a Silver Lining?

Front Immunol. 2020 Sep 30;11:586781. doi: 10.3389/fimmu.2020.586781. eCollection 2020.

Balancing Expediency and Scientific Rigor in Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development.

J Infect Dis. 2020 Jun 29;222(2):180-182. doi: 10.1093/infdis/jiaa234.

News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine.

Proc Natl Acad Sci U S A. 2020 Apr 14;117(15):8218-8221. doi: 10.1073/pnas.2005456117. Epub 2020 Mar 30.

COVID-19 vaccine design: the Janus face of immune enhancement.

Nat Rev Immunol. 2020 Jun;20(6):347-348. doi: 10.1038/s41577-020-0323-4. Epub 2020 Apr 28.

Developing Covid-19 Vaccines at Pandemic Speed.

N Engl J Med. 2020 May 21;382(21):1969-1973. doi: 10.1056/NEJMp2005630. Epub 2020 Mar 30.

Progress and Concept for COVID-19 Vaccine Development.

Biotechnol J. 2020 Jun;15(6):e2000147. doi: 10.1002/biot.202000147. Epub 2020 May 7.

引用本文的文献

A Web-Based Method for the Identification of IL6-Based Immunotoxicity in Vaccine Candidates.

Methods Mol Biol. 2023;2673:317-327. doi: 10.1007/978-1-0716-3239-0_22.

Changes of Host Immunity Mediated by IFN-γ CD8 T Cells in Children with Adenovirus Pneumonia in Different Severity of Illness.

Viruses. 2021 Nov 28;13(12):2384. doi: 10.3390/v13122384.

COVID-19 vaccines and nanomedicine.

Int J Dermatol. 2021 Sep;60(9):1047-1052. doi: 10.1111/ijd.15673. Epub 2021 Jun 5.

本文引用的文献

A Web-Based Platform on Coronavirus Disease-19 to Maintain Predicted Diagnostic, Drug, and Vaccine Candidates.

Monoclon Antib Immunodiagn Immunother. 2020 Dec;39(6):204-216. doi: 10.1089/mab.2020.0035. Epub 2020 Oct 30.

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.

Lancet. 2020 Aug 15;396(10249):467-478. doi: 10.1016/S0140-6736(20)31604-4. Epub 2020 Jul 20.

A perspective on potential antibody-dependent enhancement of SARS-CoV-2.

Nature. 2020 Aug;584(7821):353-363. doi: 10.1038/s41586-020-2538-8. Epub 2020 Jul 13.

Antibody Dependent Enhancement Due to Original Antigenic Sin and the Development of SARS.

Front Immunol. 2020 Jun 5;11:1120. doi: 10.3389/fimmu.2020.01120. eCollection 2020.

Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing.

Cell Discov. 2020 May 4;6:31. doi: 10.1038/s41421-020-0168-9. eCollection 2020.

Development of an inactivated vaccine candidate for SARS-CoV-2.

Science. 2020 Jul 3;369(6499):77-81. doi: 10.1126/science.abc1932. Epub 2020 May 6.

COVID-19: Therapeutics and Their Toxicities.

J Med Toxicol. 2020 Jul;16(3):284-294. doi: 10.1007/s13181-020-00777-5. Epub 2020 Apr 30.

Scores of coronavirus vaccines are in competition - how will scientists choose the best?

Nature. 2020 Apr 30. doi: 10.1038/d41586-020-01247-2.

The many faces of the anti-COVID immune response.

J Exp Med. 2020 Jun 1;217(6). doi: 10.1084/jem.20200678.

[Strategies for vaccine development of COVID-19].

Sheng Wu Gong Cheng Xue Bao. 2020 Apr 25;36(4):593-604. doi: 10.13345/j.cjb.200094.